£100m RB plc research and development investment in the North of England welcomed by Chancellor
Chancellor of the Exchequer, George Osborne MP, yesterday (24 July 2014) welcomed the announcement by RB (Reckitt Benckiser) to invest £100 million in its consumer health R&D (research and development) operations, with the creation of a state of the art Centre of Scientific Excellence to be based in the UK.
The announcement, which will secure over 1200 jobs and create new opportunities, was made as part of the Chancellor’s visit to RB’s major manufacturing site for consumer health and pharmaceutical products in Hull.
The project which has been supported by a £6m grant from the UK Regional Development Fund will include the development of a major new building on the site equipped with state of the art consumer health laboratory facilities; as well as the development of other existing buildings to create a modern meeting and office environment designed to encourage innovative discussion and thinking.
Work has already begun on the design and planning aspects of the project and RB expects building work to start early in 2015 with the new Centre of Technical Expertise to be fully operational by early 2018.
Chancellor of the Exchequer, George Osborne, said:
RB is a great British success story and their decision to invest in the UK is testament to the steps this government has taken to make Britain open for business.
A key part of our long term economic plan is making the UK a world leader in science and innovation, and the new state of the art Centre of Scientific Excellence will help us deliver this, giving greater economic security for hardworking people.
RB Global CEO, Rakesh Kapoor, said:
Growing our global consumer health business is at the heart of our vision to provide innovative solutions for healthier lives and happier homes. The availability of effective self-medication is a critical part of the growing socio-economic need to help individuals manage their health; and this is more than just a major investment for RB.
It is a statement of intent to change the game in consumer health. It not only shows the importance we place on innovation, but also underlines our faith in the UK as a place to invest in technical expertise and in consumer health R&D.
Latest News from
UK Infrastructure Bank Bill becomes law24/03/2023 13:25:00
The UK Infrastructure Bank Bill has received Royal Assent after being introduced to Parliament in May last year.
Spring Finance Bill 2023 published23/03/2023 12:20:00
The Bill enshrines the Chancellor’s pro-business tax and employment measures that were announced at the Budget into law.
Women in Finance charter shows continued improvements in female representation17/03/2023 10:20:00
The annual Women in Finance report published yesterday shows the finance sector is making great strides in increasing female representation in finance in senior management roles.
Chancellor unveils a Budget for growth to benefiit Scotland16/03/2023 13:17:00
A £27 billion tax cut for business and a trio of freezes to help families with the cost-of-living headlined the Chancellor’s Spring Budget.
Chancellor unveils a Budget for growth16/03/2023 10:10:00
A revolution in childcare, a £27 billion tax cut for business and a trio of freezes to help families with the cost-of-living headlined the Chancellor’s Spring Budget yesterday, Wednesday 15 March.
Spring Budget 2023 speech16/03/2023 09:10:00
Spring Budget 2023 speech as delivered by Chancellor Jeremy Hunt.
Energy bills support extended for an extra three months15/03/2023 12:05:00
Millions of households will get more support with high energy bills to help ease the cost of living, the Chancellor has announced today ahead of the Spring Budget.
Government and Bank of England facilitate sale of Silicon Valley Bank UK13/03/2023 11:20:00
Silicon Valley Bank (UK) Ltd has today been sold to HSBC